logo
Select company
Select metric
$ -33.32MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
21
Sector
21
Industry
23
History
47
$ 17Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information

Ticker

LYEL

Company Name

LYELL IMMUNOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYELL IMMUNOPHARMA INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYEL - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -33.32M
3/31/2025$ -3.92M
12/31/2024$ -38.64M
9/30/2024$ -185.91M
6/30/2024$ -90.94M
3/31/2024$ 16.23M
12/31/2023$ 22.1M
9/30/2023$ 169.91M
6/30/2023$ 18.64M
3/31/2023$ -113.17M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 42.4M.
  • Over the past 5 years, LYELL IMMUNOPHARMA INC's average CF - Chg. Cash has been $ -54.49M.
  • The median CF - Chg. Cash for LYELL IMMUNOPHARMA INC during this period was $ -27.64M
  • LYELL IMMUNOPHARMA INC reached its highest CF - Chg. Cash over the past 5 years at $ 169.91M.
  • The lowest CF - Chg. Cash recorded by LYELL IMMUNOPHARMA INC in the same timeframe $ -358.89M

LYELL IMMUNOPHARMA INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
FDMT : 4D MOLECULAR THERAPEUTICS INC $ -111.9MINMB : INMUNE BIO INC $ 2.31MHYPD : HYPERION DEFI INC $ 5.23MEPRX : EUPRAXIA PHARMACEUTICALS INC $ -3.1MVOR : VOR BIOPHARMA INC $ 114.5MTVGN : TEVOGEN BIO HOLDINGS INC $ -450.16KCRGX : CARGO THERAPEUTICS INC $ -45.84MCURX : CURANEX PHARMACEUTICALS INC -MNPR : MONOPAR THERAPEUTICS $ 33.38MTIL : INSTIL BIO INC $ 1.02M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

LYEL - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -358.89M

Minimum

Jun 30, 2022

$ 169.91M

Maximum

Sep 30, 2023

$ -54.49M

Average

$ -27.64M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.19M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.19M
median$ 116.12K
std$ 44.92M